The impact of intensive antileukaemic treatment strategies on prognosis of myelodysplastic syndrome patients aged less than 61 years according to International Prognostic Scoring System risk groups

@article{Oosterveld2003TheIO,
  title={The impact of intensive antileukaemic treatment strategies on prognosis of myelodysplastic syndrome patients aged less than 61 years according to International Prognostic Scoring System risk groups},
  author={M. Oosterveld and S. Wittebol and W. Lemmens and B. Kiemeney and A. Çatik and P. Muus and A. Schattenberg and T. D. de Witte},
  journal={British Journal of Haematology},
  year={2003},
  volume={123}
}
  • M. Oosterveld, S. Wittebol, +5 authors T. D. de Witte
  • Published 2003
  • Medicine
  • British Journal of Haematology
  • Summary. The present study applied the International Prognostic Scoring System (IPSS) to 306 consecutive myelodysplastic syndrome (MDS) patients diagnosed between August 1977 and September 2000 at the University Medical Centre Nijmegen. The aim was to investigate whether the IPSS could be used as a prognostic tool in MDS patients aged less than 61 years who were treated with acute myeloid leukaemia (AML)‐like chemotherapy with or without transplantation, and whether the scoring system… CONTINUE READING
    20 Citations
    The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes: an evidence-based review.
    • Denise M. Oliansky, J. Antin, +10 authors T. Hahn
    • Medicine
    • Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
    • 2009
    • 72
    • Highly Influenced
    • PDF
    Myelodysplasic syndromes: a comprehensive review.
    • 84
    Update on supportive care and new therapies: immunomodulatory drugs, growth factors and epigenetic-acting agents.
    • 31
    • PDF
    Myelodysplastic syndrome: An update on diagnosis and therapy
    • 4

    References

    SHOWING 1-10 OF 28 REFERENCES
    Myelodysplastic syndrome at a large tertiary care community hospital: analysis according to the international prognostic scoring system.
    • 8
    Comparisons of prognostic scoring systems for myelodysplastic syndromes: a Korean multicenter study.
    • 18
    Application of the International Prognostic Scoring System for myelodysplastic syndromes.
    • B. Maes, P. Méeus, +5 authors G. Verhoef
    • Medicine
    • Annals of oncology : official journal of the European Society for Medical Oncology
    • 1999
    • 31
    Survival analysis and AML development in patients with de novo myelodysplastic syndromes: comparison of six different prognostic scoring systems
    • 30
    Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes
    • 235